Medicines for Europe applauds compromise on SPC manufacturing waiver

14 February 2019

Today, the European Council, Parliament and Commission agreed a compromise […]

New safeguards for patient safety as Falsified Medicines Directive comes into force

8 February 2019

The EU Falsified Medicines Directive was adopted in 2011 to […]

SUPPORT a comprehensive SPC manufacturing waiver: for patient access, sustainable healthcare and manufacturing jobs

7 February 2019

SPC manufacturing waiver cannot be derailed by foreign vested interests

7 February 2019

Medicines for Europe calls on the European Council, Parliament and […]

A shared vision for better regulatory science: – Moving toward the light at the end of the tunnel

31 January 2019

This week in London, Medicines for Europe gathers regulators and […]

Efficient use of pharmacovigilance data essential for patient safety

30 January 2019

National authorities, regulators, industry leaders, and stakeholders gathered in London […]

Competition policy essential for access to medicines

28 January 2019

Medicines for Europe welcomes the publication of the European Commission […]

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Medicines for Europe welcomes today’s vote of the Legal Committee […]

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]